AzTrials
AzTrials

Cervical LengthNCT04922671

Development of a Screening Tool By Utilising Cervical Length Measurement In Relation To Body Mass Index (BMI) For Early Identification And Intervention Of Preterm Birth

An observational study of Cervical Length and Preterm Birth, run by Universiti Putra Malaysia at 2 sites in Malaysia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a prospective study where pregnant women between 16-24 weeks gestation attending the Antenatal Clinic, Fetomaternal clinic or Obstetrics \& Gynaecology Admission Centre (OGAC) at Hospital Serdang or Hospital Pengajar UPM will be recruited. BMI will be taken both during booking of pregnancy and at recruitment. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Cervical Length, Preterm Birth
How many people
145 participants
Where
2 sitesMalaysia
Study dates
1 Jun 2021to 31 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Antenatal women between 16-24 weeks gestation attending the Antenatal Clinic, Fetomaternal clinic or Obstetrics \& Gynaecology Admission Centre (OGAC) at Hospital Serdang or Hospital Pengajar UPM

Who may be able to join

  • Singleton pregnancy between 16-24 weeks gestation
  • No history of previous spontaneous preterm birth (gestation between 24-36+6 weeks)
  • Agreement to follow up and consented for the study

Who cannot join

  • Major fetal anomaly
  • Multiple pregnancy
  • Uterine anatomic malformation
  • Those require iatrogenic preterm delivery due to various condition

Trial locations and contacts

2 sites in 1 country.

Malaysia2 sites
  • Hospital Pengajar UPM

    Serdang, Selangor, 43400

  • Hospital Serdang

    Serdang, Selangor, 43400

Other trials in Malaysia

About this study

Official title: Towards Development of an Individualised Screening Tool By Utilising Cervical Length Measurement In Relation To Body Mass Index (BMI) For Early Identification And Intervention Of Preterm Birth

This is a prospective study where pregnant women between 16-24 weeks gestation attending the Antenatal Clinic, Fetomaternal clinic or Obstetrics \& Gynaecology Admission Centre (OGAC) at Hospital Serdang or Hospital Pengajar UPM will be recruited. BMI will be taken both during booking of pregnancy and at recruitment. Cervical length will be measured via transvaginal scan at recruitment time. We aim to assess the association between body mass index, cervical length and risk of preterm birth.

Read the detailed description

General Objective To assess the association between body mass index, cervical length and risk of preterm birth.

Specific Objectives

  1. To examine the relationship between body mass index and cervical length
  2. To identify cut-off value of cervical length leading to high risk of spontaneous preterm birth among Malaysian women
  3. To assess the association between different cervical length and preterm birth
  4. To examine the association between body mass index and preterm birth
  5. To develop an individualised screening tool for assessing risk of preterm birth
Keywords
body mass index, preterm labour, preterm birth, cervical length
Medical subject headings
Premature Birth, Obstetric Labor, Premature

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1. To examine the relationship between body mass index (BMI) and cervical length (CL)

    Association of BMI and CL

    Measured: till February 2023

  2. 2. To identify cut-off value of cervical length

    Value leading to high risk of spontaneous preterm birth among Malaysian women

    Measured: till February 2023

  3. 3. To assess the association between different cervical length and preterm birth

    Association of CL and PTB

    Measured: till February 2023

  4. 4. To examine the association between body mass index and preterm birth

    Association of BMI and PTB

    Measured: till February 2023

  5. 5. To develop an individualised screening tool for assessing risk of preterm birth

    Attributable risk of preterm birth with relation to BMI and CL

    Measured: Till May 2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2021
  2. Study start1 Jun 2021
  3. Primary completion28 Feb 2023
  4. Study completion31 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
145 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04922671
Sponsor's protocol ID
GM-IPM/2021/9695300
Status last verified
Nov 2023
First submitted
8 Jun 2021
Last updated
3 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cervical Length and Preterm Birth, run by Universiti Putra Malaysia at 2 sites in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1. To examine the relationship between body mass index (BMI) and cervical length (CL) (time frame: till February 2023). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in